PNC Financial Services Group Inc. Sells 223 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

PNC Financial Services Group Inc. lessened its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,053 shares of the company’s stock after selling 223 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Prestige Consumer Healthcare were worth $434,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Kayne Anderson Rudnick Investment Management LLC bought a new position in shares of Prestige Consumer Healthcare during the 4th quarter worth $84,932,000. BNP Paribas Financial Markets grew its stake in shares of Prestige Consumer Healthcare by 1,073.3% during the 4th quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company’s stock worth $15,923,000 after acquiring an additional 186,524 shares during the period. GAMMA Investing LLC grew its stake in shares of Prestige Consumer Healthcare by 11,580.3% during the 1st quarter. GAMMA Investing LLC now owns 161,538 shares of the company’s stock worth $13,887,000 after acquiring an additional 160,155 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Prestige Consumer Healthcare during the 4th quarter worth $7,778,000. Finally, Envestnet Asset Management Inc. grew its stake in shares of Prestige Consumer Healthcare by 124.4% during the 4th quarter. Envestnet Asset Management Inc. now owns 169,926 shares of the company’s stock worth $13,270,000 after acquiring an additional 94,192 shares during the period. Institutional investors own 99.95% of the company’s stock.

Wall Street Analyst Weigh In

PBH has been the subject of several research reports. Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a “hold” rating in a research note on Thursday, May 8th. Wall Street Zen downgraded Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Finally, Canaccord Genuity Group dropped their price objective on Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating on the stock in a report on Friday, August 8th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $93.33.

Prestige Consumer Healthcare Stock Performance

Shares of PBH opened at $64.60 on Friday. The stock’s 50-day simple moving average is $77.67 and its 200 day simple moving average is $81.68. The stock has a market capitalization of $3.18 billion, a price-to-earnings ratio of 15.16, a price-to-earnings-growth ratio of 2.10 and a beta of 0.43. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38. Prestige Consumer Healthcare Inc. has a 52-week low of $62.95 and a 52-week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.06). The company had revenue of $249.53 million for the quarter, compared to analysts’ expectations of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%. The business’s revenue for the quarter was down 6.6% on a year-over-year basis. During the same period last year, the company posted $0.90 EPS. Research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.